Shell Asset Management CO Heron Therapeutics, Inc. Transaction History

Shell Asset Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$14.49 - $20.72 $123,498 - $176,596	-8,523 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$10.89 - $21.47 $762 - $1,502	-70 Reduced 0.81%	8,523 $125,000
Q1 2020 May 11, 2020	SELL	$10.23 - $24.56 $1,350 - $3,241	-132 Reduced 1.51%	8,593 $101,000
Q4 2019 Feb 13, 2020	SELL	$17.42 - $26.61 $4,564 - $6,971	-262 Reduced 2.92%	8,725 $205,000
Q3 2019 Nov 12, 2019	SELL	$16.36 - $21.39 $1,259 - $1,647	-77 Reduced 0.85%	8,987 $166,000
Q2 2019 Aug 12, 2019	SELL	$16.93 - $26.22 $3,504 - $5,427	-207 Reduced 2.23%	9,064 $169,000
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $17,624 - $25,608	-800 Reduced 7.94%	9,271 $240,000
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $302,130 - $411,400	10,071 New	10,071 $319,000

181

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.